PTC Therapeutics
PTCT
#3138
Rank
ยฃ3.60 B
Marketcap
ยฃ43.13
Share price
-3.27%
Change (1 day)
-25.48%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -ยฃ62.5 Million

According to PTC Therapeutics 's latest financial reports the company's current earnings are ยฃ1.15 Billion. In 2025 the company made an earning of ยฃ0.53 Billion, an increase over its 2024 earnings that were of -ยฃ0.28 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ62.5 Million-111.74%
2025 ยฃ0.53 B-291.84%
2024 -ยฃ0.28 Billion-47.84%
2023 -ยฃ0.54 Billion18.49%
2022 -ยฃ0.45 Billion13.34%
2021 -ยฃ0.4 Billion28.64%
2020 -ยฃ0.31 Billion67.94%
2019 -ยฃ0.19 Billion87.28%
2018 -ยฃ97.93 Million64.95%
2017 -ยฃ59.37 Million-45.13%
2016 -ยฃ0.11 Billion-16.72%
2015 -ยฃ0.13 Billion72.64%
2014 -ยฃ75.26 Million90.89%
2013 -ยฃ39.43 Million96.58%
2012 -ยฃ20.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
ยฃ9.66 B-14,958.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
ยฃ3.48 B-5,460.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ88.34 Million 35.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-ยฃ0.11 Billion 53.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-ยฃ0.11 Billion 57.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-ยฃ0.53 Billion 704.62%๐Ÿ‡บ๐Ÿ‡ธ USA